Yan Kaijing and Li Yunhui signed an agreement to acquire 11% stake in Tasly Pharmaceutical Group Co., Ltd. (SHSE:600535) from Yan Xijun and Wu Nai Feng for CNY 4 million on March 27, 2016. Under the terms of the deal, Yan Xijun plans to transfer 5% stake to Yan Kaijing for CNY 1.8 million and Wu Nai Feng plans to transfer 6% stake to Li Yunhui for CNY 2.16 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.81 CNY | -0.44% | +2.26% | -7.11% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.11% | 3.27B | |
+40.09% | 6.16B | |
-16.34% | 4.46B | |
+5.14% | 3.2B | |
-0.18% | 2.6B | |
+47.93% | 1.98B | |
-7.15% | 1.7B | |
+0.67% | 1.66B | |
-8.73% | 1.61B | |
+48.97% | 1.54B |
- Stock Market
- Equities
- 600535 Stock
- News Tasly Pharmaceutical Group Co., Ltd
- Yan Kaijing and Li Yunhui signed an agreement to acquire 11% stake in Tasly Pharmaceutical Group Co., Ltd. from Yan Xijun and Wu Nai Feng for CNY 4 million.